APAnastazja Poczta-Krawczyk

Anastazja Poczta-Krawczyk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anastazja Poczta-Krawczyk has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Paclitaxel-Loaded Polyelectrolyte Nanocarriers: Uptake Mechanisms, Cytotoxicity, and Genotoxicity in Human Endothelial and Breast Cancer Cells

    by Marzena Szwed, Anastazja Poczta-Krawczyk, Katarzyna Dominika Kania, Karol Bukowski, Katarzyna Bednarska-Szczepaniak, Agnieszka Marczak, Krzysztof Szczepanowicz

    Purpose: This study explores the therapeutic potential of sodium dodecyl sulphate (SDS)-based nanocarriers (NCs) for the targeted delivery of paclitaxel (PTX) to breast cancer (BC) cells, with a particular focus on the mechanisms governing their intracellular transport and biological activity. Methods: Two types of SDS-based NCs differing in polyelectrolyte composition: poly-L-lysine (SDS/PLL) and poly-L-lysine with poly-L-glutamic acid (SDS/PLL/PGA), were prepared following the Layer-by-Layer (LbL) technique. Cellular uptake and distribution of Rhodamine B (RhoB)-labelled NCs were assessed via fluorescence microscopy and quantified by flow cytometry across three human cell lines: dermal microvascular endothelial cell line (HMEC-1), epithelial breast adenocarcinoma cell line (MCF-7), and triple-negative, mesenchymal-like BC cell line (MDA-MB-231). The cytotoxic and genotoxic effects of PTX-loaded NCs were evaluated using spectrophotometric and spectrofluorimetric assays. In parallel, DNA damage-responsive gene expression was examined by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). Results: Both NC formulations demonstrated comparable uptake efficiency, despite differences in fluorescence intensity. Inhibitor-based studies revealed distinct internalization pathways: SDS/PLL NCs entered via dynamin-dependent endocytosis and macropinocytosis, whereas SDS/PLL/PGA NCs relied predominantly on macropinocytosis. Genotoxicity of PTX-loaded NCs was confirmed by comet assay and H2A histone family member X (γH2AX) phosphorylation, particularly in MCF-7 and MDA-MB-231 cells. Cell cycle perturbations and transcriptional changes in ataxia-telangiectasia mutated (ATM), ATM and Rad3-related (ATR), and cyclin-dependent kinase 1 (CDK1) genes accompanied these effects. Enzyme-linked immunosorbent assay (ELISA)-based analyses further demonstrated apoptosis-mediated cytotoxicity induced by both investigated formulations. Conclusion: These findings delineate the cellular uptake mechanisms and in vitro biological effects of the examined polyelectrolyte NCs for PTX delivery, with a particular focus on their genotoxicity. Collectively, these in vitro data provide a mechanistic basis to inform the rational design and preclinical optimization of SDS-based NCs, supporting subsequent in vivo evaluation.


  • Open Access

    Nanoparticle-Mediated Ferroptosis for Cancer Therapy: Mechanisms and Therapeutic Strategies

    by Marzena Szwed, Anastazja Poczta-Krawczyk, Karol Bukowski, Agnieszka Marczak

    Ferroptosis, an iron-dependent form of regulated cell death, is increasingly leveraged in nanomedicine to sensitise tumours and overcome drug resistance. Driven by the Fenton reaction, ferroptosis results in lipid peroxidation through elevated intracellular iron levels and excessive production of reactive oxygen species (ROS). In this review, we outline the molecular markers of ferroptosis and define the criteria necessary to attribute ferroptosis induction to nanoparticles (NPs). We emphasise the importance of distinguishing targeted ferroptosis from non-specific ROS-mediated nanotoxicity and other types of programmed cell death. This distinction requires the use of lipophilic radical-trapping antioxidants (eg, ferrostatin-1, liproxstatin-1), iron chelators, and evidence implicating glutathione peroxidase 4 (GPX4) or the system Xc− antiporter. Morphology is considered supportive but non-diagnostic, requiring converging evidence from both biochemical and genetic sources. We then compare various nanosystems designed to induce ferroptosis, such as iron-based nanoparticles, lipid nanocarriers, light-triggered nanoparticles, and magnetically induced nanocarriers, highlighting mechanistic patterns, efficacy determinants, and common pitfalls that often occur during biological investigations. Finally, we discuss translational challenges, including tumour microenvironment heterogeneity, NP protein corona dynamics, clearance and off-target effects. We aim to provide a framework that links NP design to ferroptotic mechanisms and clinically relevant outcomes, offering clear criteria and priorities for future research.